Select Medical to Go Private in $3.9 Billion Consortium Deal — Select Medical Holdings Corporation

Event summary

Select Medical Holdings Corporation to be acquired by a consortium led by Robert A. Ortenzio, Martin F. Jackson, and WCAS for $3.9 billion in enterprise value.
Deal values shares at $16.50 each, an 18% premium over the unaffected share price as of November 24, 2025.
Transaction expected to close mid-2026, subject to regulatory approvals and stockholder votes.
Current management to remain in place post-merger, with existing debt expected to remain outstanding.

The big picture

This deal marks a significant shift in healthcare services consolidation, with private equity firms increasingly targeting large-scale operators. The $3.9 billion valuation reflects confidence in Select Medical's extensive network of critical illness recovery and rehabilitation facilities. The transaction underscores the trend of public healthcare companies going private to streamline operations and pursue growth strategies away from public market scrutiny.

What we're watching

Regulatory Approval: Whether the transaction clears antitrust review under the Hart-Scott-Rodino Act, given Select Medical's extensive U.S. operations.
Management Continuity: How the retention of current management impacts operational stability and strategic direction post-transaction.
Private Equity Strategy: The pace at which WCAS and the consortium execute growth initiatives and acquisitions to enhance Select Medical's market position.